Breast Cancer & Cannabis

The Breast Cancer & Cannabis program explores how cannabinoid therapeutics may support symptom management, comfort, and quality of life during breast cancer care.

Breast cancer treatment can involve pain, fatigue, anxiety, nausea, appetite changes, sleep disruption, and emotional strain. This self-paced mini-module is designed for patients, caregivers, nurses, and healthcare professionals who want a clearer understanding of how cannabis may fit into integrative cancer care. Nurses can earn 2 continuing education hours upon successful completion of the program and evaluation.

Grounded in current research and guided by nursing expertise, Cannabinoid Therapeutics for Breast Cancer connects conventional oncology care with evidence-informed cannabinoid education. Learners explore the endocannabinoid system, breast cancer subtypes, cannabinoid pharmacology, dosing considerations, safety, and real-world case examples.

What You’ll Learn

• The endocannabinoid system (ECS) and its relationship to cancer biology and symptom regulation
• The historical, legal, and regulatory context of cannabis in medicine
• Research and clinical considerations related to ER+/PR+, HER2+, and Triple-Negative Breast Cancer
• How cannabinoids such as CBD, THC, CBG, CBDA, and THCA are being studied in relation to inflammation, pain, and cancer-related pathways
• Practical dosing, product selection, routes of administration, and safety considerations
• Real-world case studies demonstrating different approaches to cannabinoid use during breast cancer care
• Integrative lifestyle strategies that may support the endocannabinoid system and overall well-being

Why It Matters

Cannabinoid therapeutics may offer another tool for supporting comfort and quality of life during breast cancer treatment. Understanding the science, potential benefits, limitations, and safety considerations can help patients and healthcare professionals make more informed decisions about cannabis as part of an integrative care plan.